SCHEMBL19557282

SCHEMBL19557282

CCc1cccc2c1cc([Si](CC)(CC)CC)n2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPEPPS P55786 1/20 0.42
TLR8 Q9NR97 1/20 0.35
GPR3 P46089 1/20 0.34
KDM4E B2RXH2 4/20 0.33
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
DAO P14920 2/20 0.33
NQO2 P16083 1/20 0.33
DDO Q99489 1/20 0.33
LMNA P02545 3/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TSHR P16473 2/20 0.32
TP53 P04637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ALDH1A1 P00352 3/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HTT P42858 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30444571 0.86 NPEPPS (0.34) NPEPPSGPR3LMNAL3MBTL1
SCHEMBL17504849 0.86 NPEPPS (0.34) NPEPPSGPR3LMNAL3MBTL1
SCHEMBL29509065 0.82 ALKBH5 (0.42) NPEPPSTLR8GPR3KDM4ENQO2
SCHEMBL17504843 0.82 ALKBH5 (0.42) NPEPPSTLR8GPR3KDM4ENQO2
SCHEMBL12278274 0.78 MAPT (0.36) GPR3KDM4EGAAMAPTL3MBTL1
SCHEMBL22434745 0.76 NPEPPS (0.46) NPEPPSGPR3KDM4EGABRA1GABRB2
SCHEMBL30444626 0.73 KMT2A (0.46) KDM4EDAOMAPTALDH1A1HPGD
SCHEMBL15639678 0.73 KMT2A (0.46) KDM4EDAOMAPTALDH1A1HPGD
SCHEMBL23095471 0.69 NPEPPS (0.50) NPEPPSGPR3KDM4EGABRA1GABRB2
SCHEMBL17504848 0.69 RPS6KA5 (0.39) KDM4ELMNAGAAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753421-B2 Silylated derivatives of aromatic heterocycles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-09-12 US disclosed
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS CALIFORNIA INSTITUTE OF TECHNOLOGY 2018-03-01 US disclosed
US-9809607-B2 Silylation of aromatic heterocycles by earth abundant transition-metal-free catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180057514-A1 SILYLATION OF AROMATIC HETEROCYCLES BY EARTH ABUNDANT TRANSITION-METAL-FREE CATALYSTS TEC, AURKA, TYR NPEPPS 2421/4885TLR8 3378/4885GPR3 4000/4885
US-11753421-B2 Silylated derivatives of aromatic heterocycles KCNH1, KCNH3, HNRNPH3 NPEPPS 4054/4885TLR8 3595/4885GPR3 3589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.